Similarly, Pertot and colleagues reported the lack of predictive power for insulin therapy for GDM using maternal characteristics including race/ethnicity, BMI, family history of diabetes, hemoglobin A1c, and glucose levels [31]. The gene discussed is INS; the disease is gestational diabetes.